Search results
Richmond speaks up: Letters to the editor for the week of Apr. 19, 2024
Richmond Times-Dispatch· 3 hours agoApril 29 is the first World Liver Day that millions of patients with a common liver disease can...
Liver diseases in kids up due to junk food, sugar consumption
Investing.com· 19 hours agoLucknow, April 19 (IANS) Medical experts have found that one in three children have non-alcoholic...
She Wasn’t a Match to Be Her Boyfriend’s Donor, But Still Saved a Life. Then He Proposed: 'It Was...
People Magazine· 3 hours agoBack in 2022, Brandon Morgan, now 27, received crushing news: his changes of surviving liver disease...
Friday, April 19, is celebrated as World Liver Day for the first time
Hardwood Paroxysm· 9 hours agoThus, April 19 becomes a day to demand greater attention to all liver diseases. “Although the causes...
Gastrointestinal cancers: What symptoms you should look out for as colon cancer rates rise in young...
Yahoo Canada Style· 3 days agoColon cancer rates are rising in young Canadians. Here's what to know about risks for different...
New Weight-Loss Drugs Are Meant to Be Lifelong. What Happens When You Quit?
Scientific American· 8 hours agoWegovy, Ozempic and similar weight-loss drugs have become some of the most popular medications in...
Black women hospitalized in US with blood infection resistant to last-resort antibiotic at increased...
Medical Xpress· 2 hours agoNew research being presented at this year's ESCIMD Global Congress (formerly ECCMID) in Barcelona,...
Fatty liver disease affecting one in five young adults, Bristol study shows
BBC via AOL· 3 days agoProf Nic Timpson, principal investigator at Children of the 90s, says the data "will enable...
Tiny ingestible beads could help fight liver disease: study
WFMZ Eastern Pennsylvania and Western New Jersey· 4 days agoTiny ingestible carbon beads could help fight liver disease and keep our guts healthy, a new study...
Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
Morningstar· 4 hours agoHepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma ...